BROOKLYN IMMUNOTHERAPEUTICS - COM (BTX)

CUSIP: 114082100

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -8,602,838
Total reported value: $0
Number of holders: 0
Value change: -$2,123,000
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 114082100?
CUSIP 114082100 identifies BTX - BROOKLYN IMMUNOTHERAPEUTICS - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2022

Recent filing periods for CUSIP 114082100:

Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

There are no holders of BTX - BROOKLYN IMMUNOTHERAPEUTICS - COM as of Q4 2022.